Question 1

Is N-Butilbromuro De Hioscina + Paracetamol currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, N-Butilbromuro De Hioscina + Paracetamol has 3 active shortage notices across 1 country (Peru). Status is refreshed daily from official regulatory sources.

Question 2

Why is N-Butilbromuro De Hioscina + Paracetamol in shortage?

Accepted Answer

Regulators attribute the current N-Butilbromuro De Hioscina + Paracetamol shortages to raw-material (API) supply problems, causes not stated by the regulator, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the N-Butilbromuro De Hioscina + Paracetamol shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 5 Dec 2023 to 16 Mar 2029, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this N-Butilbromuro De Hioscina + Paracetamol shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

N-Butilbromuro De Hioscina + Paracetamol shortage status

Where N-Butilbromuro De Hioscina + Paracetamol is in shortage

Why N-Butilbromuro De Hioscina + Paracetamol is in shortage

Frequently asked questions

Get alerted when N-Butilbromuro De Hioscina + Paracetamol status changes